Skip to main content
Skip to main navigation menu
Skip to site footer
Open Menu
Home
Current
Archives
Manuscript Submission
Announcements
Editorial Review Board
Permissions and Licensing
Subscription Information
Advertising Information
Library Referral Form
Library Referral Form - Online
Reprints
The Future of Opioids
Special Issue on Buprenorphine
Special on Legal and Regulatory Aspects of Opioids
Webinars
BUPE2024
User License Agreement
Call for Papers - Updated
About
About the Journal
Editorial Team
Privacy Statement
Contact
Search
Register
Login
Home
/
Archives
/
Vol. 16 No. 3 (2020): May/June
Vol. 16 No. 3 (2020): May/June
Published:
05/01/2020
Letters to the Editor
Potential pharmacological perspectives for the treatment/prevention of the SARS-COV-2 infection in opioid dependent patients
Maurizio Coppola, MD, Raffaella Mondola, MD
165-166
PDF
Articles
The impact of an innovative pharmacist-led inpatient opioid de-escalation intervention in post-operative orthopedic patients
Thuy Bui, BPharm, Richard Grygiel, MPharm, Alex Konstantatos, MB BS (Hons), FANZCA, Dip Obs, MRCA, Nick Christelis, Susan Liew, MB BS (Hons), FRACS, Ria Hopkins, BHSci (Hons), MPH, Michael Dooley, BPharm, Grad DipHospPharm, PhD
167-176
Requires Subscription or Fee
PDF
(USD 56)
Factors associated with participation and nonparticipation in a VA Whole Health Primary Care Pain Education and Opioid Monitoring Program (PC-POP)
Amber Martinson, PhD, Amanda Kutz, PhD, William Marchand, MD, Julie Carney, RN, Jamie Clinton-Lont, MS, CNP
179-188
Requires Subscription or Fee
PDF
(USD 56)
Evaluation and analysis of the Modified Finnegan Scoring System for assessment of neonatal abstinence syndrome
Rafia Q. Baloch, MD, Jamie M. Pinto, MD, Patricia Greenberg, MS, Yen-Hong Kuo, PhD, Anita Siu, PharmD, BCPPS
189-196
Requires Subscription or Fee
PDF
(USD 56)
National gender differences in the prescribing of opioid medications from 2006 to 2015
Salena Marie Preciado, MS, Daniel Tomaszewski, PharmD, PhD, T. Craig Cheetham, PharmD, MS, Tania Gregorian, PharmD, Sharon Xavioer, PharmD, BCACP, Souhiela Fawaz, BPharm (Hons), PhD
197-208
Requires Subscription or Fee
PDF
(USD 56)
An open-label, randomized, single-dose, two-period, two-treatment crossover bioavailability study comparing 5 mg/0.5 mL of intramuscular naloxone hydrochloride to 2 mg/0.4 mL intramuscular naloxone hydrochloride autoinjector in healthy subjects
Ronald B. Moss, MD, Fiona Carleton, PhD, Charles P. Lollo, PhD, Dennis J. Carlo, PhD
209-214
Requires Subscription or Fee
PDF
(USD 56)
Clinical Report
Cannabidiol (CBD) as a treatment of acute and chronic back pain: A case series and literature review
Jonathan P. Eskander, MD, MBA, Junaid Spall, BS, Awais Spall, BA, Rinoo V. Shah, MD, MBA, Alan D. Kaye, MD, PhD
215-218
Requires Subscription or Fee
PDF
(USD 56)
Managing breakthrough pain for advanced malignancy in elderly patients: A real challenge
Deepti Ahuja, MD, Nandan Choudhary, MD, Vinod Kumar, MD, Nishkarsh Gupta, MD, Sachidanand Jee Bharati, DM
219-222
Requires Subscription or Fee
PDF
(USD 56)
Brief Communication
Incidence and correlates of opioid-related psychiatric emergency care: A retrospective, multiyear cohort study
Anees Bahji, MD
223-226
Requires Subscription or Fee
PDF
(USD 56)
Patient and pediatric caregiver experiences and expectations about opioid risk education and counselling
Tanvee Thakur, BPharm, MS, Betty Chewning, PhD
227-232
Requires Subscription or Fee
PDF
(USD 56)
Full Issue
Volume 16, Number 3
161-232
Requires Subscription or Fee
PDF
(USD 56)
Old JOM header
ad_block_3
Subscription
Login to access subscriber-only resources.
Make a Submission
Make a Submission
Information
For Readers
For Authors
For Librarians
Keywords
Announcements